This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
AstraZeneca PLC has divested some more non-core assets to Grunenthal GMBH, this time granting the company rights to its GERD therapy Nexium (esomoprezole) and arthritis product Vimovo (esomoprezole/naproxen).
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?